Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Bionic Eye Market, by Technology
1.4.2 North America Bionic Eye Market, by End Use
1.4.3 North America Bionic Eye Market, by Type
1.4.4 North America Bionic Eye Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Bionic Eye Market by Technology
3.1 North America Electronic Market by Country
3.2 North America Mechanical Market by Country
Chapter 4. North America Bionic Eye Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Eye Clinics Market by Country
4.3 North America Other End uses Market by Country
Chapter 5. North America Bionic Eye Market by Type
5.1 North America Implanted Eye Bionic Eye Market by Country
5.2 North America External Eye Bionic Eye Market by Country
Chapter 6. North America Bionic Eye Market by Country
6.1 US Bionic Eye Market
6.1.1 US Bionic Eye Market by Technology
6.1.2 US Bionic Eye Market by End-use
6.1.3 US Bionic Eye Market by Type
6.2 Canada Bionic Eye Market
6.2.1 Canada Bionic Eye Market by Technology
6.2.2 Canada Bionic Eye Market by End-use
6.2.3 Canada Bionic Eye Market by Type
6.3 Mexico Bionic Eye Market
6.3.1 Mexico Bionic Eye Market by Technology
6.3.2 Mexico Bionic Eye Market by End-use
6.3.3 Mexico Bionic Eye Market by Type
6.4 Rest of North America Bionic Eye Market
6.4.1 Rest of North America Bionic Eye Market by Technology
6.4.2 Rest of North America Bionic Eye Market by End-use
6.4.3 Rest of North America Bionic Eye Market by Type
Chapter 7. Company Profiles
7.1 Second Sight Medical Products, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.1.4 Recent strategies and developments:
7.1.4.1 Geographical Expansions:
7.2 Pixium Vision S.A.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Research & Development Expenses
7.2.4 Recent strategies and developments:
7.2.4.1 Approvals:
7.3 Nidek Co., Ltd.
7.3.1 Company Overview
7.4 Optobionics Corporation
7.4.1 Company Overview
7.5 Biomedical Technologies S.L.
7.5.1 Company Overview
7.6 Bionic Vision Technologies Pty. Ltd.
7.6.1 Company Overview
7.7 Monash Vision Group
7.7.1 Company Overview
7.8 The Bionic Eye (The Bionic Group)
7.8.1 Company Overview
7.9 Nano Retina Ltd.
7.9.1 Company Overview
7.1 iBionics
7.10.1 Company Overview
Unique Offerings 
